AGING DISEASE--TRANSGENIC/VIROLOGIC/IMMUNOLOGIC STUDIES
AGING DISEASE--TRANSGENIC/VIROLOGIC/IMMUNOLOGIC STUDIES
批准号:
6356212
负责人:
MICHAEL B OLDSTONE
金额:
$14.93万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-09-30 至 2000-11-30
关键词:
Alzheimer's disease MHC class I antigen aging amyloid proteins apoptosis astrocytes chemoprevention cytotoxic T lymphocyte disease /disorder model gene expression gene targeting genetic polymorphism genetically modified animals helper T lymphocyte immune tolerance /unresponsiveness immunocytochemistry immunopathology laboratory mouse neurons pathologic process prions scrapie tumor necrosis factor alpha virus genetics western blottings
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Transmissible spongiform encephalopathies (TSE) (prion disease, scrapie)
are fatal neurodegenerative diseases that occur in humans and animals.
This grant's focus is on elucidating the pathogenic mechanism(s)
contributing to the neuronal injury and on utilizing molecular
approaches to treat and/or about disease. We hypothesize that the
disease of the CNS characterize by spongiosis, astrocytosis, neural
death, neural dropout and accumulation of an abnormal isoform (PrP/sc)
from the host-encoded cellular PrP (PrP/c) occurs by two distinct
pathways. The first is by direct accumulation of PrP/sc in neurons.
However, the presence of exogenous PrP/c delays/aborts the onset of
disease. A major aim of this proposal is to continue studies and to
expand the evaluation of exogenous PrP/c in aborting/treating TSE
disease. The second major aim of this proposal evaluates the possibility
that neuronal injury also occurs from bystander (indirect) effects. TNF-
alpha, a cytokine-implicated in apoptosis, is markedly increased in the
CNS during scrapie disease. TNF-alpha expression parallels the onset of
clinical symptoms and experiments using TNF-alpha ko mice are designed
to determine its role in disease. In addition, in prion + (mPrP+) but
not in prion/null (ko) (mPrP/null) mice, inoculation of murine scrapie
leads to infiltration of T lymphocytes into the brain that parallels the
clinical course of disease. Initial experiments show it takes a
significantly longer time for MHC class I ko mice given murine scrapie
agent to develop clinical and histological scrapie when compared to MHC
class I sufficient mice, strongly suggesting that CD8+ T cells may
contribute to the pathogenesis of scrapie when compared to MHC class I
sufficient mice, strongly suggesting that CD8+ T cells may contribute to
the pathogenesis of scrapie. The enigma of immune tolerance to PrP is to
be re-evaluated. The role played by MHC molecules and T cell subsets in
the pathogenesis of TSE disease will be investigated, and regions on PrP
recognized by T cell determined.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Host Genetic Factors to Combat Lassa Hemorrhagic Fever
-
批准号:8573827
-
项目类别:
-
资助金额:$44.53万
-
财政年份:2013
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Host Genetic Factors to Combat Lassa Hemorrhagic Fever
-
批准号:8711266
-
项目类别:
-
资助金额:$47.38万
-
财政年份:2013
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Host Genetic Factors to Combat Lassa Hemorrhagic Fever
-
批准号:9118852
-
项目类别:
-
资助金额:$48.13万
-
财政年份:2013
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Pathogenesis of Acute Respiratory Diseases: SARS and INFLUENZA
-
批准号:8609326
-
项目类别:
-
资助金额:$32.47万
-
财政年份:2012
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Novel Chemical and Immunological Approaches to Influenza Therapy
-
批准号:7288013
-
项目类别:
-
资助金额:$160.69万
-
财政年份:2007
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Novel Chemical and Immunological Approaches to Influenza Therapy
-
批准号:8076285
-
项目类别:
-
资助金额:$163.57万
-
财政年份:2007
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
In Vivo Analysis of T lymphocytes in the Persistently Infected CNS
-
批准号:7570017
-
项目类别:
-
资助金额:$46.47万
-
财政年份:2007
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Novel Chemical and Immunological Approaches to Influenza Therapy
-
批准号:7626430
-
项目类别:
-
资助金额:$162.72万
-
财政年份:2007
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Novel Chemical and Immunological Approaches to Influenza Therapy
-
批准号:7864328
-
项目类别:
-
资助金额:$165.57万
-
财政年份:2007
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Novel Chemical and Immunological Approaches to Influenza Therapy
-
批准号:7433177
-
项目类别:
-
资助金额:$158.34万
-
财政年份:2007
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
In Vivo Analysis of T lymphocytes in the Persistently Infected CNS
-
批准号:8026029
-
项目类别:
-
资助金额:$45.55万
-
财政年份:2007
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
In Vivo Analysis of T lymphocytes in the Persistently Infected CNS
-
批准号:7767714
-
项目类别:
-
资助金额:$46.01万
-
财政年份:2007
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Therapeutics to Prevent/Treat Lassa Fever Virus
-
批准号:7064252
-
项目类别:
-
资助金额:$45.82万
-
财政年份:2004
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Therapeutics to Prevent/Treat Lassa Fever Virus
-
批准号:7218663
-
项目类别:
-
资助金额:$44.49万
-
财政年份:2004
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Therapeutics to Prevent/Treat Lassa Fever Virus
-
批准号:7578818
-
项目类别:
-
资助金额:$47.48万
-
财政年份:2004
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Therapeutics to Prevent/Treat Lassa Fever Virus
-
批准号:6817720
-
项目类别:
-
资助金额:$31.28万
-
财政年份:2004
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Therapeutics to Prevent/Treat Lassa Fever Virus
-
批准号:6891327
-
项目类别:
-
资助金额:$46.93万
-
财政年份:2004
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Therapeutics to Prevent/Treat Lassa Fever Virus
-
批准号:7842621
-
项目类别:
-
资助金额:$47.48万
-
财政年份:2004
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Therapeutics to Prevent/Treat Lassa Fever Virus
-
批准号:7394464
-
项目类别:
-
资助金额:$44.07万
-
财政年份:2004
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
Therapeutics to Prevent/Treat Lassa Fever Virus
-
批准号:6668779
-
项目类别:
-
资助金额:$46.93万
-
财政年份:2003
-
负责人:MICHAEL B OLDSTONE
-
依托单位:
海外基金